374 related articles for article (PubMed ID: 25826649)
41. The effect of intranasal administration of oxytocin on fear recognition.
Fischer-Shofty M; Shamay-Tsoory SG; Harari H; Levkovitz Y
Neuropsychologia; 2010 Jan; 48(1):179-84. PubMed ID: 19747930
[TBL] [Abstract][Full Text] [Related]
42. A common oxytocin receptor gene (OXTR) polymorphism modulates intranasal oxytocin effects on the neural response to social cooperation in humans.
Feng C; Lori A; Waldman ID; Binder EB; Haroon E; Rilling JK
Genes Brain Behav; 2015 Sep; 14(7):516-25. PubMed ID: 26178189
[TBL] [Abstract][Full Text] [Related]
43. Medial prefrontal cortex stimulation accelerates therapy response of exposure therapy in acrophobia.
Herrmann MJ; Katzorke A; Busch Y; Gromer D; Polak T; Pauli P; Deckert J
Brain Stimul; 2017; 10(2):291-297. PubMed ID: 27931887
[TBL] [Abstract][Full Text] [Related]
44. Do oral contraceptives modulate the effects of stress induction on one-session exposure efficacy and generalization in women?
Raeder F; Merz CJ; Tegenthoff M; Dere E; Wolf OT; Margraf J; Schneider S; Zlomuzica A
Psychopharmacology (Berl); 2023 May; 240(5):1075-1089. PubMed ID: 36894736
[TBL] [Abstract][Full Text] [Related]
45. Oxytocin enhances the recovery of eye-contact induced autonomic arousal: A treatment mechanism study with placebo-controlled design.
Daniels N; Prinsen J; Soriano JR; Alaerts K
Eur Neuropsychopharmacol; 2020 Oct; 39():87-98. PubMed ID: 32868176
[TBL] [Abstract][Full Text] [Related]
46. Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up.
Alaerts K; Steyaert J; Vanaudenaerde B; Wenderoth N; Bernaerts S
Eur Neuropsychopharmacol; 2021 Feb; 43():147-152. PubMed ID: 33309460
[TBL] [Abstract][Full Text] [Related]
47. Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome.
Hall SS; Lightbody AA; McCarthy BE; Parker KJ; Reiss AL
Psychoneuroendocrinology; 2012 Apr; 37(4):509-18. PubMed ID: 21862226
[TBL] [Abstract][Full Text] [Related]
48. Treatment effect on biases in size estimation in spider phobia.
Shiban Y; Fruth MB; Pauli P; Kinateder M; Reichenberger J; Mühlberger A
Biol Psychol; 2016 Dec; 121(Pt B):146-152. PubMed ID: 26987423
[TBL] [Abstract][Full Text] [Related]
49. Influence of intranasal oxytocin on fear consolidation in healthy humans.
Hoge E; Bui E; Rosencrans P; Orr S; Ross R; Ojserkis R; Simon N
Gen Psychiatr; 2019; 32(6):e100131. PubMed ID: 31922086
[TBL] [Abstract][Full Text] [Related]
50. Long-term exposure to intranasal oxytocin in a mouse autism model.
Bales KL; Solomon M; Jacob S; Crawley JN; Silverman JL; Larke RH; Sahagun E; Puhger KR; Pride MC; Mendoza SP
Transl Psychiatry; 2014 Nov; 4(11):e480. PubMed ID: 25386957
[TBL] [Abstract][Full Text] [Related]
51. The Effects of Oxytocin on Withdrawal, Craving and Stress Response in Heroin-Dependent Patients: A Randomized, Double-Blind Clinical Trial.
Moeini M; Omidi A; Sehat M; Banafshe HR
Eur Addict Res; 2019; 25(1):41-47. PubMed ID: 30630161
[TBL] [Abstract][Full Text] [Related]
52. Sleep enhances exposure therapy.
Kleim B; Wilhelm FH; Temp L; Margraf J; Wiederhold BK; Rasch B
Psychol Med; 2014 May; 44(7):1511-9. PubMed ID: 23842278
[TBL] [Abstract][Full Text] [Related]
53. Oxytocin-Augmented Modular-Based Group Intervention for Loneliness: A Proof-Of-Concept Randomized Controlled Trial.
Berger R; Hurlemann R; Shamay-Tsoory S; Kanterman A; Brauser M; Gorni J; Luhmann M; Schramm E; Schultz J; Philipsen A; Lieberz J; Scheele D
Psychother Psychosom; 2024; 93(3):169-180. PubMed ID: 38754399
[TBL] [Abstract][Full Text] [Related]
54. The relative contributions of fear and disgust reductions to improvements in spider phobia following exposure-based treatment.
Olatunji BO; Huijding J; de Jong PJ; Smits JA
J Behav Ther Exp Psychiatry; 2011 Mar; 42(1):117-21. PubMed ID: 20732677
[TBL] [Abstract][Full Text] [Related]
55. The Scarier the Better: Maximizing Exposure Therapy Outcomes for Spider Fear.
Norberg MM; Newins AR; Jiang Y; Xu J; Forcadell E; Alberich C; Deacon BJ
Behav Cogn Psychother; 2018 Nov; 46(6):754-760. PubMed ID: 30001760
[TBL] [Abstract][Full Text] [Related]
56. Intranasal oxytocin compensates for estrus cycle-specific reduction of conditioned safety memory in rats: Implications for psychiatric disorders.
Kreutzmann JC; Fendt M
Neurobiol Stress; 2021 May; 14():100313. PubMed ID: 33778132
[TBL] [Abstract][Full Text] [Related]
57. The acute effects of intranasal oxytocin administration on endocrine and sexual function in males.
Burri A; Heinrichs M; Schedlowski M; Kruger TH
Psychoneuroendocrinology; 2008 Jun; 33(5):591-600. PubMed ID: 18375074
[TBL] [Abstract][Full Text] [Related]
58. Effects of intranasal insulin as an enhancer of fear extinction: a randomized, double-blind, placebo-controlled experimental study.
Ferreira de Sá DS; Römer S; Brückner AH; Issler T; Hauck A; Michael T
Neuropsychopharmacology; 2020 Apr; 45(5):753-760. PubMed ID: 31896118
[TBL] [Abstract][Full Text] [Related]
59. Augmenting exposure therapy with pre-extinction fear memory reactivation and deepened extinction: A randomized controlled trial.
Lancaster CL; Monfils MH; Telch MJ
Behav Res Ther; 2020 Dec; 135():103730. PubMed ID: 33096291
[TBL] [Abstract][Full Text] [Related]
60. Extinction retention predicts improvement in social anxiety symptoms following exposure therapy.
Berry AC; Rosenfield D; Smits JA
Depress Anxiety; 2009; 26(1):22-7. PubMed ID: 18781661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
